Overview Request Sample Pages Request Customization Download PDF
You are viewing: North America Companion Animal Diagnostic Market analysis

The North America Companion Animal Diagnostic Market was valued at $1704.5 Million in 2026 and projected to reach to $2556.2 Million by 2031, representing a compound annual growth rate of 8.4%. North America's companion animal diagnostic market is poised for sustained expansion, with the region's mature veterinary infrastructure and high pet ownership rates creating a stable foundation for growth.

North America Companion Animal Diagnostic Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

North America Companion Animal Diagnostic Market Trends and Insights

  • This 8.4% compound annual growth rate reflects North America's strong pet ownership rates, advanced veterinary infrastructure, and increasing consumer spending on pet healthcare.
  • North America leads globally in adoption of diagnostic technologies, driven by rising awareness of preventive care and early disease detection in companion animals. The North America market benefits from established veterinary networks, high pet insurance penetration, and significant investment in diagnostic innovation.
  • North America's regulatory environment supports rapid adoption of new diagnostic modalities, including point-of-care testing and advanced imaging solutions.
  • Pet owners in North America increasingly demand comprehensive diagnostic services, positioning the region as a critical growth engine for the global companion animal diagnostic sector through 2031..

Key Market Statistics

  • CAGR (2026-2031) 8.4% CAGR
  • Market Size, 2026 ~USD 1704.5 Million
  • Forecast, 2031 ~USD 2556.2 Million
  • Geography North America

North America Companion Animal Diagnostic Market Overview

Market Leadership Position :

North America commands the largest share of the global companion animal diagnostic market, driven by the highest pet ownership rates and premium spending on veterinary care across the US and Canada.

Strong Growth Trajectory :

With an 8.4% CAGR from 2026 to 2031, North America's market is expanding faster than many developed regions, reflecting increasing demand for advanced diagnostic technologies in veterinary practices.

Advanced Veterinary Infrastructure :

North America benefits from sophisticated veterinary networks, widespread adoption of point-of-care diagnostics, and high integration of digital health solutions in companion animal care.

Consumer Spending Momentum :

Rising pet humanization trends and increased consumer willingness to invest in preventive and diagnostic care are driving sustained market expansion across both the US and Canadian markets.

North America Companion Animal Diagnostic Market Dynamics

  • The market's 8.4% CAGR reflects strong consumer demand for advanced diagnostic solutions, including imaging, laboratory testing, and point-of-care devices.
  • Increasing pet healthcare spending, driven by pet humanization trends and growing awareness of preventive care, will continue to fuel market development through 2031. The region's competitive landscape features established diagnostic manufacturers and emerging technology providers investing in innovative solutions tailored to North American veterinary practices.
  • Integration of digital diagnostics, telemedicine platforms, and AI-powered diagnostic tools is expected to accelerate adoption rates.
  • Both the US and Canadian markets will benefit from regulatory support for veterinary innovation and strong reimbursement frameworks, positioning North America as the global leader in companion animal diagnostics..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • North America's companion animal diagnostic market will grow from $1,704.5M (2026) to $2,556.2M (2031) at an 8.4% CAGR.
    • North America dominates global adoption of advanced diagnostic technologies including point-of-care testing and digital imaging.
    • High pet ownership rates and pet insurance penetration in North America drive sustained demand for diagnostic services.
    • North America's established veterinary infrastructure and regulatory support accelerate innovation and market expansion through 2031.

    Companion Animal Diagnostic Market Report Scope

    Report Metric Details
    Base Year 2026
    Fastest Growing Segment MOLECULAR DIAGNOSTICS (Technology)
    Forecast Period 2026–2031
    Growth Rate CAGR of 8.7% from 2026 to 2031
    Largest Segment CONSUMABLES (Product)
    Market Size Base Year (Billions) ~USD 3.56 (2026)
    Revenue Forecast (Billions) ~USD 5.4 (2031)
    Segments Covered Product, Technology, Type, Application, Animal Type, End User

    North America Companion Animal Diagnostic Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Product

    • Consumables
    • Instruments

    By Technology

    • Clinical Biochemistry
    • Hematology
    • Immunodiagnostics
    • Molecular Diagnostics
    • Other Technologies
    • Urinalysis

    By Type

    • Allergen-Specific Immunodiagnostic Tests
    • Blood Gas & Electrolyte Analysis
    • Blood Gas & Electrolyte Analyzers
    • Blood Gas & Electrolyte Reagents, Clips, And Cartridges
    • Blood Glucose Strips
    • Clinical Chemistry Analysis
    • Clinical Chemistry Analyzers
    • Clinical Chemistry Reagents, Clips, And Cartridges
    • Elisa Tests
    • Glucose Monitoring
    • Glucose Monitors
    • Hematology Analyzers
    • Hematology Cartridges
    • Immunoassay Analyzers
    • Lateral Flow Assays
    • Microarrays
    • Nucleic Acid Sequencing
    • Other Immunodiagnostics Products
    • Other Molecular Diagnostics Products
    • Pcr Tests
    • Radioimmunoassays
    • Rapid Tests
    • Strip Readers
    • Urinalysis Clips & Cartridges
    • Urine Analyzers
    • Urine Glucose Strips
    • Urine Test Strips

    By Application

    • Bacteriology
    • Clinical Pathology
    • Other Applications
    • Parasitology
    • Virology

    By Animal Type

    • Cats
    • Dogs
    • Horses
    • Other Companion Animals

    By End User

    • Home Care Settings
    • Veterinary Hospital & Clinics
    • Veterinary Reference Laboratories
    • Veterinary Research Institutes & Universities

    Target Audience

    • Veterinary Diagnostic Manufacturers : Manufacturers need North America-specific market data to optimize product portfolios, identify growth segments, and develop region-tailored marketing strategies for the world's largest companion animal diagnostic market.
    • Veterinary Practice Operators : Practice owners and managers require market insights to make informed decisions about diagnostic equipment investments, technology upgrades, and service expansion aligned with regional demand trends.
    • Investment & Private Equity Firms : Investors evaluating opportunities in the veterinary healthcare sector need detailed North American market analysis to assess growth potential, competitive dynamics, and acquisition targets in diagnostics.
    • Healthcare Technology Companies : Digital health and AI solution providers need North America market intelligence to understand adoption barriers, competitive landscape, and revenue opportunities in companion animal diagnostics.
    • Market Research & Consulting Professionals : Analysts and consultants require granular North American data to support client advisory work, competitive benchmarking, and strategic recommendations in the veterinary diagnostics sector.

    Key Companies in the North America Companion Animal Diagnostic Market

    CompanyHQOwnershipStrongest segments
    MINDRAY MEDICAL INTERNATIONAL LIMITEDChinaPrivate CompanyPatient Monitoring and Life Support Products,In-Vitro Diagnostic Products,Medical Imaging Systems,
    QIAGEN NVNetherlandsPublic CompanySample technology consumables and instruments,Immune response and infectious disease diagnostics (incl. TB IGRA, transplant, viral load),Oncology, sexual and reproductive health assays,
    IDEXX LABORATORIES, INC.United StatesPublic CompanyCompanion Animal Group – in-clinic analyzers and SNAP rapid assays,Companion Animal Group – reference laboratories and telemedicine/consulting,Veterinary software, services, VetConnect PLUS and VetLab Station,
    FUJIFILM CORPORATIONJapanPublic CompanyHealthcare (medical devices, CDMO, pharma, regenerative medicine, cosmetics/supplements),Business Innovation (office equipment, document solutions, graphic communications, inkjet),Electronics (display, semiconductor materials, storage, industrial equipment, fine chemicals),
    THERMO FISHER SCIENTIFIC INC.United StatesPublic CompanyLife Sciences Solutions,Analytical Instruments,Specialty Diagnostics,
    BIOMéRIEUXFrancePublic CompanyClinical microbiology (culture media, VITEK 2, VITEK MS, AST including ETEST/VITEK REVEAL),Syndromic and molecular diagnostics (BIOFIRE, BIOFIRE SPOTFIRE, ARGENE, EMAG/NUCLISENS),Immunoassays and CLIA (VIDAS, Hybiome),
    BIONOTESouth KoreaPublic CompanyVeterinary fluorescence immunoassay and molecular diagnostics,Veterinary clinical biochemistry systems and reagents,Veterinary rapid immunoassay and ELISA kits,
    VIRBACFrancePublic CompanyCompanion-animal parasiticides and anti-infectives,Companion-animal specialty therapeutics & behavior (CKD diets, pheromones, mobility),Farm-animal vaccines (swine focus: Suigen range),

    MINDRAY MEDICAL INTERNATIONAL LIMITED

    Mindray Medical International Limited is a Chinese medical device manufacturer founded in 1991 with 8,400 employees. Operating as a private company, it specializes in diagnostic and monitoring equipment for healthcare applications.

    QIAGEN NV

    QIAGEN NV is a Dutch public company founded in 1984 with 5,500 employees. It provides molecular diagnostics, sample preparation, and life sciences research tools globally.

    IDEXX LABORATORIES, INC.

    IDEXX Laboratories, Inc. is a United States-based public company founded in 1983 with 11,000 employees. The company develops and manufactures diagnostic equipment and software for veterinary and water testing markets.

    FUJIFILM CORPORATION

    Fujifilm Corporation is a Japanese public company founded in 1934 with 73,526 employees. It operates across imaging, diagnostics, pharmaceuticals, and industrial products globally.

    THERMO FISHER SCIENTIFIC INC.

    Thermo Fisher Scientific Inc. is a United States public company founded in 1956 with 125,000 employees. It is a leading provider of laboratory equipment, reagents, and analytical instruments worldwide.

    BIOMéRIEUX

    bioMérieux is a French public company founded in 1963 with 14,894 employees. It specializes in in vitro diagnostics and microbiology testing solutions for clinical and industrial applications.

    BIONOTE

    BioNote is a South Korean public company founded in 2003 with 298 employees. The company develops and manufactures diagnostic devices and reagents for veterinary and clinical use.

    VIRBAC

    Virbac is a French public company founded in 1968 with 6,442 employees. It specializes in veterinary pharmaceuticals and animal health products.

    North America vs. other regions

    HowNorth America compares to the other 3 regional blocs covered in this market.

    Europe
    ~USD 1337.7 Million · 8.1% wtd CAGR ·
    Asia Pacific
    ~USD 1247.5 Million · 10.1% wtd CAGR ·
    Latin America
    ~USD 172.2 Million · 7.5% wtd CAGR ·
    Middle East & Africa
    ~USD 84.3 Million · 6.1% wtd CAGR ·

    Countries within North America - compare and drill down

    Country2025 size (native)
    USUSD 1532.5 Million
    CanadaUSD 180.7 Million

    Country market size visualization

    US
    USD 1532.5 Million
    Canada
    USD 180.7 Million

    Reasons to Buy this Report

    • Market Size & Growth Data : Access precise market valuations for North America ($1,704.5M in 2026) with detailed forecasts through 2031, enabling accurate business planning and investment decisions specific to the region.
    • Country-Level Breakdown : Understand market dynamics across the US ($1,532.5M) and Canada ($180.7M) separately, allowing targeted strategies for each country's unique veterinary landscape and consumer preferences.
    • Competitive Intelligence : Identify growth opportunities and competitive positioning within North America's advanced diagnostic market, including insights on technology adoption rates and market consolidation trends.
    • Strategic Market Insights : Leverage region-specific analysis of pet ownership trends, veterinary infrastructure development, and consumer spending patterns to inform product development and market entry strategies.
    • Forecast Reliability : Benefit from detailed 5-year projections grounded in North America's established market data, regulatory environment, and economic indicators for confident long-term planning.

    Frequently asked questions

    What is the current size of North America's companion animal diagnostic market?

    North America's companion animal diagnostic market is valued at $1,704.5 million in 2026, representing a significant portion of global companion animal diagnostics spending.

    What is the projected market size for North America by 2031?

    North America's companion animal diagnostic market is forecast to reach $2,556.2 million by 2031, reflecting sustained growth in pet healthcare spending and diagnostic adoption.

    What is the CAGR for North America's companion animal diagnostic market?

    North America's companion animal diagnostic market is projected to grow at a compound annual growth rate of 8.4% from 2026 to 2031.

    What factors drive growth in North America's companion animal diagnostic market?

    North America's market growth is driven by high pet ownership, increased pet insurance coverage, rising consumer spending on preventive care, and rapid adoption of advanced diagnostic technologies.

    How does North America compare to other regions in companion animal diagnostics?

    North America leads globally in diagnostic technology adoption, veterinary infrastructure maturity, and pet healthcare spending, positioning it as the largest regional market for companion animal diagnostics.

    RESEARCH METHODOLOGY

    This research study extensively utilized both primary and secondary sources. It involved analyzing various factors influencing the industry to identify segmentation types, industry trends, key players, the competitive landscape, key market dynamics, and strategies employed by key players.

    Secondary Research

    This research study utilized a variety of comprehensive secondary sources, including directories, databases such as Bloomberg Business, Factiva, and Dun & Bradstreet, white papers, annual reports, company house documents, investor presentations, and SEC filings from various companies. Secondary research was employed to gather information crucial for an in-depth, technical, market-oriented, and commercial analysis of the companion animal diagnostics market. This approach also helped identify key players in the industry and allowed for classification and segmentation based on emerging trends at the most detailed level. Furthermore, significant developments pertaining to both market and technological perspectives were documented. A database of primary industry leaders was created as part of this secondary research.

    Primary Research

    In the primary research process, we interviewed a range of sources from both the supply and demand sides to gather qualitative and quantitative information for this report. Primary sources from the supply side include project/sales/marketing/business development managers, presidents, CEOs, vice presidents, chairpersons, chief operating officers, chief strategy officers, directors, chief information officers, and chief medical information officers related to the companion animal diagnostics market. Primary sources from the demand side include R&D product development teams in animal health companies, veterinary clinicians, diagnostic laboratory managers, and procurement heads at veterinary reference laboratories.

    Companion Animal Diagnostic Market Size, and Share

    Note: C-level executives include CEOs, COOs, CTOs, and VPs. Other designations include sales, marketing, and product managers.
    Tiers are defined based on a company’s total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The total size of the companion animal diagnostics market was determined through data triangulation across three approaches, as described below. After each approach, the weighted average of the three was calculated based on the level of assumptions used in each.

    Companion Animal Diagnostic Market Top Down and Bottom Up Approach

    Data Triangulation

    After arriving at the market size, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed as applicable to complete the overall market engineering process and obtain exact statistics for all segments and subsegments.

    Market Definition

    Companion animal diagnostics use plasma, serum, blood, urine, feces, and tissue samples to detect, monitor, and manage diseases and health conditions in dogs, cats, horses, and other household pets. The companion animal diagnostics market includes diagnostic instruments, test kits, reagents, and consumables used in veterinary clinics and laboratories, covering technologies such as clinical chemistry analyzers, hematology analyzers, immunodiagnostics and ELISA test kits, urinalysis systems, molecular diagnostic assays, glucose monitoring systems, and blood gas–electrolyte analyzers. These products support routine wellness screening, disease diagnosis, treatment monitoring, and preventive healthcare in companion animals.

    Key Stakeholders

    • Companion animal diagnostic manufacturers
    • Companion animal diagnostic distributors and suppliers
    • Companion animal R&D companies
    • Veterinary reference laboratories
    • Veterinary hospitals and clinics
    • Veterinary universities and research institutes
    • Government associations
    • Market research and consulting firms
    • Venture capitalists and investors
    • Distributors, channel partners, and third-party suppliers

    Report Objectives

    • To define, describe, segment, and forecast the companion animal diagnostics market by product, technology, application, animal type, end user, and region
    • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall companion animal diagnostics market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the companion animal diagnostics market in five main regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
    • To profile the key players in the companion animal diagnostics market and comprehensively analyze their core competencies and market shares
    • To analyze competitive developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships

    Available customizations:

    Based on the given market data, MarketsandMarkets offers customization to meet your company’s specific needs. The following customization options are available for the report:

    Company Information
    • Detailed analysis and profiling of additional market players (up to 5)
    Geographic Analysis
    • Further breakdown of the Rest of European companion animal diagnostics market into Austria, Finland, Switzerland, and other countries
    • Further breakdown of the Rest of Latin American companion animal diagnostics market into Colombia, Chile, and other countries
    Competitive Landscape Assessment
    • Market share analysis for North America and Europe, which provides market shares of the top 3–5 key players in the companion animal diagnostics market
    • Competitive leadership mapping for established players in the US

     

    Get the Full Companion Animal Diagnostic Market Report

    Full forecast, segment splits, and company analysis for all Companion Animal Diagnostic Market.

    Download Sample Pages Buy Report

    METHODOLOGY

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    Cite this Research
    DMCA.com Protection Status